In last trading session, Ventyx Biosciences Inc (NASDAQ:VTYX) saw 1.16 million shares changing hands with its beta currently measuring 0.51. Company’s recent per share price level of $1.69 trading at -$0.03 or -1.74% at ring of the bell on the day assigns it a market valuation of $119.50M. That closing price of VTYX’s stock is at a discount of -579.29% from its 52-week high price of $11.48 and is indicating a premium of 7.1% from its 52-week low price of $1.57.

For Ventyx Biosciences Inc (VTYX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 8 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.55 in the current quarter.

Ventyx Biosciences Inc (NASDAQ:VTYX) trade information

Upright in the red during last session for losing -1.74%, in the last five days VTYX remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $1.69 price level, adding 5.28% to its value on the day. Ventyx Biosciences Inc’s shares saw a change of -22.83% in year-to-date performance and have moved 4.32% in past 5-day. Ventyx Biosciences Inc (NASDAQ:VTYX) showed a performance of -16.34% in past 30-days.

Wall Street analysts have assigned a consensus price target of 45 to the stock, which implies a rise of 96.24% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 60. It follows that stock’s current price would drop -255.03% in reaching the projected high whereas dropping to the targeted low would mean a loss of -255.03% for stock’s current value.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -148.81% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 36.48% while estimates for its earnings growth in next 5 years are of 18.81%.

Ventyx Biosciences Inc (NASDAQ:VTYX)’s Major holders

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at VTYX for having 5.83 million shares of worth $13.47 million. And as of 2024-06-30, it was holding 9.4284 of the company’s outstanding shares.

The second largest institutional holder is CITADEL ADVISORS LLC, which was holding about 5.76 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.3133 of outstanding shares, having a total worth of $13.3 million.